Psoriatic arthritis (PsA) patients who also qualified for a diagnosis of metabolic syndrome were far more likely to meet criteria for a difficult-to-treat (D2T) form of their rheu ...

Two studies suggest there is no significant benefit of early biologics over standard step-up care with methotrexate, but ...

APEX shows Tremfya is the first IL-23 inhibitor to slow joint damage in psoriatic arthritis, offering early, multi-domain ...

About one-third of psoriasis sufferers develop psoriatic arthritis, with swelling, tenderness and pain in joints, affecting daily activities and lifestyle. Psoriatic arthritis (PsA) is a chronic ...

UCB has announced new three-year data from phase 3 trials and their open-label extensions investigating BIMZELX (bimekizumab) ...

EULAR - The European Alliance of Associations for Rheumatology - recommends a treat-to-target approach, and suggests more ...

Dr. Michael Garshick discusses recently published recommendations for cardiovascular risk screening for patients with ...

Two recent studies suggest there is no significant benefit of early biologics over standard step-up care with methotrexate2,3, but these did not ...

Enthesitis is a key, but often overlooked, feature of psoriatic arthritis. Learn how this inflammation at tendon and ligament attachment sites can affect diagnosis, symptoms, and treatment.

A range of things can cause a psoriasis flare-up, including stress, cold weather (hello winter!), skin injuries, certain ...